Application 209554
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOBRAMYCIN | TOBRAMYCIN | SOLUTION;INHALATION | 300MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209554-001 | TOBRAMYCIN | TOBRAMYCIN | 300MG/5ML | SOLUTION / INHALATION | 2017-10-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A209554-001 | TOBRAMYCIN | 300MG/5ML | SOLUTION / INHALATION | 2017-10-13 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A209554-001 | TOBRAMYCIN | 300MG/5ML | SOLUTION / INHALATION | 2017-10-13 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A209554-001 | TOBRAMYCIN | 300MG/5ML | SOLUTION / INHALATION | 2017-10-13 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A209554-001 | AN | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A209554-001 | AN | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A209554-001 | AN | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A209554-001 | AN | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TOBRAMYCIN | TOBRAMYCIN | Lifestar Pharma LLC | 5563e8af-c6c9-42a2-974d-7d364a47f00a | 2026-07-29 | Warnings, Adverse reactions | TOBRAMYCIN TOBRAMYCIN |
| TOBRAMYCIN | TOBRAMYCIN | NorthStar RxLLC | 7803ac83-1250-451b-8ad8-2c0a343c3031 | 2026-07-29 | Warnings, Adverse reactions | TOBRAMYCIN TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | Preferred Pharmaceuticals Inc. | 417623f1-ed48-41f5-a4b4-6f2e4a23891e | 2026-07-15 | Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | St. Mary's Medical Park Pharmacy | 9263df93-c558-5d9f-e053-2995a90a546c | 2026-06-22 | Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| TOBI Podhaler | TOBRAMYCIN | Viatris Specialty LLC | c4b5bb1f-e158-4ac1-9c35-e98a416c743a | 2026-04-15 | Warnings, Adverse reactions | TOBRAMYCIN |
| TOBRAMYCIN | TOBRAMYCIN | Hospira, Inc. | c5a005b0-7b6f-4e30-df92-9a20b1ca66a1 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | TOBRAMYCIN TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | Sportpharm LLC | e2aa8499-2eab-4ea2-b122-6c7b1ad0c35c | 2026-03-20 | Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | Xiromed LLC | 8b50d1b5-ea8a-5844-358a-493f1965c07f | 2026-02-23 | Boxed warning, Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| tobramycin | TOBRAMYCIN | Slate Run Pharmaceuticals, LLC | ed254eec-10f4-425a-895b-66e325b7bf69 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | tobramycin TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | Sportpharm LLC | 6ded47a3-d5c0-4616-8b7d-d6d0e6bce2a0 | 2026-02-05 | Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | NuCare Pharmaceuticals,Inc. | b119bfa5-33b0-84eb-e053-2995a90a2cad | 2026-02-04 | Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | JVET PHARMACEUTICALS LLC | c6435b8f-bb6e-45e0-a52b-3087fd043b5a | 2026-01-26 | Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | REMEDYREPACK INC. | 3596dacc-6abc-45eb-8085-fa7aaa580a1c | 2026-01-21 | Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | American Health Packaging | f2f8bf02-57f8-4d34-937a-32411fc6bfba | 2025-12-22 | Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| TOBREX | TOBRAMYCIN | Novartis Pharmaceuticals Corporation | 5b66bba3-cf97-4a9c-b618-ba5f277f20f6 | 2025-12-16 | Warnings, Adverse reactions | TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | Ritedose Pharmaceuticals, LLC | e8205898-0162-4e6c-bcf1-87cb074ab9ae | 2025-12-10 | Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| TOBI | TOBRAMYCIN | Viatris Specialty LLC | 6a3c3871-1d3a-44d6-8be3-526b30123ef7 | 2025-11-15 | Warnings, Adverse reactions | TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | XGen Pharmaceuticals DJB, Inc. | a384641c-04e3-4ab5-b152-7408cd07b64d | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | Northstar Rx LLC | 55d09ffd-4f32-8aeb-3904-8a17db635e3a | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
| Tobramycin | TOBRAMYCIN | Somerset Therapeutics, LLC | 7333280d-5d2a-4609-ab93-3ab7031b65db | 2025-07-10 | Warnings, Adverse reactions | Tobramycin TOBRAMYCIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.